Results 251 to 260 of about 87,017 (286)
Some of the next articles are maybe not open access.

ACE inhibitors

Abstract ACE inhibitors were first introduced because of their vasodilatory properties. It is now understood that the beneficial effects arise from the antagonism of the renin–angiotensin–aldosterone system. ACE inhibitors are first-line agents for all patients with HFrEF—this is also true in patients with asymptomatic LVSD.
Roy S. Gardner   +3 more
openaire   +1 more source

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

ACE Inhibitors

Reactions Weekly, 2018
Alec Ren, Philip A. Rea
openaire   +2 more sources

ACE Inhibitors

Reactions Weekly, 2008
openaire   +2 more sources

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Misty M Attwood, Stefan Knapp
exaly  

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors   +2 more
exaly  

Home - About - Disclaimer - Privacy